Nikeith John

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing¹⁷⁷Lu-PSMA-I&T Therapy

Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker et al. · Journal of Nuclear Medicine · 2022 · 70 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database

Louise Emmett, Nathan Papa, William Counter et al. · Journal of Nuclear Medicine · 2023 · 42 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)

Louise Emmett, Nikeith John, Sarennya Pathmanandavel et al. · Therapeutic Advances in Medical Oncology · 2023 · 39 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen–Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer

Louise Emmett, Nathan Papa, Thomas A. Hope et al. · The Journal of Urology · 2024 · 27 citations · Full text

Medicine, Oncology, Urology +17

Development of a Visually Calculated SUV_mean(HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to¹⁷⁷Lu-PSMA Therapy: Comparison with Quantitative SUV_meanand Patient Outcomes

Mina Swiha, Nathan Papa, Zahra Sabahi et al. · Journal of Nuclear Medicine · 2024 · 25 citations · Full text

Medicine, Nuclear Medicine, Oncology +17